Sana Biotechnology will cut 15% of its workforce in latest layoffs affecting Seattle companies
GeekWire
NOVEMBER 30, 2022
Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday. The company said it was shutting a program focused on heart failure and outlined reset priorities for other programs. Data are expected in 2023. Sana CEO Steve Harr. Sana Photo).
Let's personalize your content